(Sep 11, 2008 01:50 PM)Protein Tomography™ has yet again provided structural proof of a drug target function. A study performed by Sidec and UCB, characterizes the target of anti-epileptic drug in situ where two major conformations have been identified.
(Jun 05, 2008 04:25 PM)Sidec has of today introduced a new version of its Protein Tomography™ technology. The new developments drastically improve the analysis of therapeutic antibodies and drug targets in biological systems.
(May 27, 2008 07:56 AM)Sidec announces that the application form for the 2008 Protein Tomography™ Award is now available at Sidec’s homepage. The winning application will be offered a Protein Tomography™ study in collaboration with Sidec. A Protein Tomography™ study is typically in the range of 0.1 and 0.5 million Euro and will be funded by Sidec.
More Press & Company News articles
(Nov 21, 2006 01:20 PM)Several methods are available for the study of antibody-antigen complexes. Present techniques, however, rely on indirect measurements of antibody binding, and do not reveal any information on what the antibody-antigen complex and possible associated proteins look like. Protein Tomography™ makes it possible, for the first time, to see antibodies free or bound to their target, both in solution and in tissue. To see the article, please click on the link,
http://www.nature.com/nmeth/journal/v3/n11/index.htm
(Aug 24, 2006 11:00 AM)Published in Nature Reviews Drug Discovery, August 2006
(May 15, 2006 03:00 PM)View protein tomograms in 3-D and download recent PNAS publication.
More Press & Company News articles
Subscribe to our RSS feed to stay updated on all news from Sidec.
News & Press RSS feed (What is RSS?)